Study of Betatrophin Levels in Patients With Type 2 Diabetes and Gestational Diabetes and Healthy Subjects
NCT ID: NCT02025673
Last Updated: 2014-01-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2013-08-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Sensitive CRP in Prediabetics and Diabetes
NCT03673904
The Characteristics of Blood Glucose Profile and the Changes of Hormones in PPDM-C Population
NCT06826729
The Effect of Contrast Agent on Endothelial Function in Healthy Men
NCT01895699
An Observational Study on Post-chronic Pancreatitis Diabetes Mellitus
NCT05764629
Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus
NCT00762671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Controls
Healthy subjects as control group.
No interventions assigned to this group
Type 2 diabetes
Patients with type 2 diabetes.
No interventions assigned to this group
Gestational diabetes mellitus
Patients with gestational diabetes mellitus.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with HbA1c \>or= 7.0%
Exclusion Criteria
* Type 1 diabetes mellitus patients
* Patients with history of severe hepatic dysfunction
* Treatment with antifungal agent especially Miconazole
* Patients with active smoking or history of smoking cessation less than 2 months
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qingdao University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jing Dong
associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jing Dong, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Medical College of Qingdao University
References
Explore related publications, articles, or registry entries linked to this study.
Espes D, Lau J, Carlsson PO. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia. 2014 Jan;57(1):50-3. doi: 10.1007/s00125-013-3071-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Betatrophin-Human
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.